0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing%20spondylitis" gave back 267 results.
The global Arthritic Therapeutic market was valued at US$ 27240 million in 2023 and is anticipated to reach US$ 35210 million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global PDE 4 Inhibitors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global JAK1 Inhibitors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Humira Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0% CAGR during the forecast...
Catalog:
GIR
June 2023
Price: USD 4,480.00
TNF Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about TNF Antibodies –Biosimilars and Biosuperiors provides...
Catalog:
La Merie Publishing
March 2014
Price: USD 551.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Adalimumab Monoclonal Antibody Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Anti-TNF-α Monoclonal Antibody market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
TNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are at least 80 types of autoimmune...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and...
Catalog:
LPI
March 2023
Price: USD 3,660.00
